Description
Short-chain fatty acid concentrations in stool samples are analyzed as a mechanistic outcome of the synbiotic intervention.
Figure 25
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 25: Short-chain fatty acid concentrations in stool samples are analyzed as a mechanistic outcome of the synbiotic intervention.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Short-chain fatty acid concentrations in stool samples are analyzed as a mechanistic outcome of the synbiotic intervention." /> <figcaption>Figure 25. Short-chain fatty acid concentrations in stool samples are analyzed as a mechanistic outcome of the synbiotic intervention.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
Preuves associées
B
Bifidobacterium longum pour Irritable Bowel Syndrome (IBS)
B
Note B · 4 études
Galactooligosaccharides (GOS) pour Irritable Bowel Syndrome (IBS)
B
Note B · 3 études
Lactobacillus acidophilus pour Irritable Bowel Syndrome (IBS)
D
Note B · 3 études
Fructooligosaccharides (FOS) pour Irritable Bowel Syndrome (IBS)
Note D · 2 études